Two Sigma Investments’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-27,800
| Closed | -$44.2K | – | 3374 |
|
|
2024
Q1 | $44.2K | Sell |
27,800
-462,716
| -94% | -$736K | ﹤0.01% | 2812 |
|
|
2023
Q4 | $421K | Buy |
490,516
+83,688
| +21% | +$71.9K | ﹤0.01% | 2467 |
|
|
2023
Q3 | $435K | Buy |
406,828
+70,394
| +21% | +$75.3K | ﹤0.01% | 2265 |
|
|
2023
Q2 | $871K | Sell |
336,434
-5,588
| -2% | -$14.5K | ﹤0.01% | 1946 |
|
|
2023
Q1 | $1.4M | Buy |
342,022
+62,832
| +23% | +$256K | ﹤0.01% | 1601 |
|
|
2022
Q4 | $1.4M | Buy |
279,190
+19,250
| +7% | +$96.6K | ﹤0.01% | 1472 |
|
|
2022
Q3 | $3.4M | Buy |
259,940
+91,020
| +54% | +$1.19M | 0.01% | 887 |
|
|
2022
Q2 | $2.17M | Buy |
168,920
+21,722
| +15% | +$279K | 0.01% | 1112 |
|
|
2022
Q1 | $2.25M | Sell |
147,198
-89,461
| -38% | -$1.36M | 0.01% | 1269 |
|
|
2021
Q4 | $4.19M | Buy |
236,659
+28,339
| +14% | +$502K | 0.01% | 969 |
|
|
2021
Q3 | $4.38M | Buy |
208,320
+194,420
| +1,399% | +$4.09M | 0.01% | 977 |
|
|
2021
Q2 | $274K | Sell |
13,900
-54,247
| -80% | -$1.07M | ﹤0.01% | 2153 |
|
|
2021
Q1 | $1.98M | Buy |
+68,147
| New | +$1.98M | 0.01% | 1276 |
|
|
2020
Q4 | – | Sell |
-49,542
| Closed | -$788K | – | 2526 |
|
|
2020
Q3 | $788K | Buy |
49,542
+727
| +1% | +$11.6K | ﹤0.01% | 1254 |
|
|
2020
Q2 | $964K | Buy |
+48,815
| New | +$964K | ﹤0.01% | 1171 |
|